LifeVantage (NASDAQ:LFVN - Get Free Report) announced its earnings results on Wednesday. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.08, Zacks reports. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%.
LifeVantage Trading Up 1.7 %
Shares of NASDAQ LFVN traded up $0.32 during mid-day trading on Friday, reaching $19.31. The company had a trading volume of 580,134 shares, compared to its average volume of 317,488. The stock has a market cap of $242.34 million, a P/E ratio of 34.48 and a beta of 0.84. LifeVantage has a 52-week low of $5.22 and a 52-week high of $27.38. The firm has a 50 day simple moving average of $19.33 and a two-hundred day simple moving average of $13.78.
LifeVantage Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 3rd will be paid a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 0.83%. The ex-dividend date is Monday, March 3rd. LifeVantage's dividend payout ratio is presently 28.57%.
Analyst Upgrades and Downgrades
A number of research firms have recently weighed in on LFVN. Craig Hallum started coverage on shares of LifeVantage in a report on Tuesday, January 14th. They issued a "buy" rating and a $35.00 price target on the stock. Lake Street Capital began coverage on LifeVantage in a research report on Thursday, December 19th. They set a "buy" rating and a $26.00 price target for the company.
View Our Latest Analysis on LifeVantage
About LifeVantage
(
Get Free Report)
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
Recommended Stories

Before you consider LifeVantage, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeVantage wasn't on the list.
While LifeVantage currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.